Ancillary T Cell Based Studies in SPIROMICS

Completed

Conditions studied: Smoke Induced Lung Disease

In brief

The long-term objectives of this ancillary application are to characterize a subpopulation of smokers with auto-reactive T cell response, to validate immunodiagnostic assays that could detect emphysema, and to find molecular signatures for pathogenic T cell development in a well-characterized cohort participating in SPIROMICS (UCSF center).

Key facts

Study ID

NCT02036190

Run by

University of California, San Francisco

People needed

175

Starts

2012-02-01

Expected to finish

2016-01-01

Last updated by the study team

2016-06-03

Who can join

Age: 40 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 4o, former or active smokers

You may not qualify if…

• HIV infection, chronic hepatitis B and C, immune suppressive medications.

Where it is running

• UCSF — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.